Remedor Biomed has a total of 37 patents globally, out of which 13 have been granted. Of these 13 patents, more than 78% patents are active USA is where Remedor Biomed has filed the maximum number of patents, followed by Japan. Parallelly, the USA seems to be the main focused R&D centre and also is the origin country of Remedor Biomed.
Remedor Biomed was founded in 2014. Leading biotechnology company Remedor Biomed is set to take the lead in the regenerative medicine and wound care industries.
Do read about some of the most popular patents of Remedor Biomed which have been covered by us in this article and also you can find Remedor Biomed patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Remedor Biomed patent portfolio.
How many patents do the CEO of Remedor Biomed have?
The Founder Dr. Saher HAMED (Also CEO) has 41 patents.
How many patents does Remedor Biomed have?
Remedor Biomed has a total of 37 patents globally. These patents belong to 7 unique patent families. Out of 37 patents, 26 patents are active.
How Many Patents did Remedor Biomed File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Remedor Biomed Applications Filed | Remedor Biomed Patents Granted |
| 2023 | – | 2 |
| 2022 | 1 | 2 |
| 2021 | 2 | – |
| 2020 | 1 | 3 |
| 2019 | 1 | 1 |
| 2018 | 2 | 3 |
| 2017 | – | – |
| 2016 | 13 | 1 |
| 2015 | 1 | 1 |
| 2014 | 1 | – |
| 2011 | 1 | – |
How many Remedor Biomed patents are Alive/Dead?
Worldwide Patents
How Many Patents did Remedor Biomed File in Different Countries?
Countries in which Remedor Biomed Filed Patents
| Country | Patents |
| United States Of America | 10 |
| Japan | 5 |
| Israel | 3 |
| Europe (EPO) | 3 |
| China | 2 |
| Germany | 2 |
| Austria | 2 |
| Brazil | 1 |
| Australia | 1 |
| Russia | 1 |
| Canada | 1 |
| Viet Nam | 1 |
| Korea (South) | 1 |
| Poland | 1 |
| Hong Kong (S.A.R.) | 1 |
Where are Research Centers of Remedor Biomed Patents Located?
10 Best Remedor Biomed Patents
US20110123481A1 is the most popular patent in the Remedor Biomed portfolio. It has received 9 citations so far from companies like Stemetrix, Inc, and Zhuhai Yingsheng Lianke Biotechnology Co Ltd.
Below is the list of 10 most cited patents of Remedor Biomed:
| Publication Number | Citation Count |
| US20110123481A1 | 9 |
| US20140154205A1 | 7 |
| WO2017037655A1 | 7 |
| US20100310626A1 | 6 |
| CN102906250A | 3 |
| CN107427559A | 2 |
| US11213569B2 | 1 |
| US10792338B2 | 0 |
| US20220339252A1 | 0 |
| US20220000987A1 | 0 |
What Percentage of Remedor Biomed US Patent Applications Were Granted?
Remedor Biomed (Excluding its subsidiaries) has filed 6 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 33.33%.
Below are the key stats of Remedor Biomed patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Remedor Biomed?
| Law Firm | Total Applications | Success Rate |
| Norton Rose Fulbright Us Llp | 6 | 33.33% |
List of Remedor Biomed Patents –
| Remedor Biomed Patents | Title |
| US11213569B2 | Topical Erythropoietin Formulations And Methods For Improving Wound Healing With And Cosmetic Use Of The Formulations |
| US10792338B2 | Erythropoietin And Fibronectin Compositions For Therapeutic And Cosmetic Applications |
| US20220339252A1 | Topical Erythropoietin Formulations And Methods For Improving Wound Healing With And Cosmetic Use Of The Formulations |
| US20220000987A1 | Erythropoietin And Fibronectin Compositions For Therapeutic And Cosmetic Applications |
| US20100310626A1 | Erythropoietin And Fibronectin Compositions For Bone Regeneration |
| EP2268301B1 | Erythropoietin And Fibronectin Compositions For Bone Regeneration |
| EP2192907B1 | Erythropoietin And Fibronectin Compositions For Therapeutic Applications |
| EP3344229A1 | Topical Erythropoietin Formulations And Methods For Improving Wound Healing With And Cosmetic Use Of The Formulations |
| CN107427559A | Topical Erythropoietin Formulations And Methods For Improving Wound Healing With And Cosmetic Use Of The Formulations |
| JP7242065B2 | Topical Erythropoietin Formulations And Methods For Improving Wound Healing Using The Formulations And Cosmetic Uses Of The Formulations |
| JP7242298B2 | Topical Erythropoietin Formulations And Methods For Improving Wound Healing Using The Formulations And Cosmetic Uses Of The Formulations |
| JP5869219B2 | Erythropoietin And Fibronectin Compositions For Therapeutic And Cosmetic Applications |
| JP5829400B2 | Erythropoietin And Fibronectin Compositions For Bone Regeneration |
| JP2022177241A5 | Topical Erythropoietin Formulations And Methods For Improving Wound Healing Using Said Formulations And Cosmetic Uses Of Said Formulations |
| KR1020180049036A | Topical Erythropoietin Formulations And Methods For Improving Wound Healing With And Cosmetic Use Of The Formulations |
| CA3035830A1 | Topical Erythropoietin Formulations And Methods For Improving Wound Healing With And Cosmetic Use Of The Formulations |
| DE602009061267T2 | Erythropoietin And Fibronectin Compositions For New Bone Formation |
| DE602008054909T2 | Erythropoietin And Fibronectin Compositions For Therapeutic Applications |
| PL2192907T3 | Erythropoietin And Fibronectin Compositions For Therapeutic Applications |
| RU2777367C2 | Local Erythropoietin Compositions, Methods For Improvement Of Wound Healing, And Cosmetic Use Of Compositions |
| AU2016314611C1 | Topical Erythropoietin Formulations And Methods For Improving Wound Healing With And Cosmetic Use Of The Formulations |
| IL257795A | Topical Erythropoietin Formulations And Methods For Improving Wound Healing With And Cosmetic Use Of The Formulations |
| VN61635A | Erythropoietin Pharmaceutical Use Only To Promote The Would Healing |
| HK1246177A | Topical Erythropoietin Formulations And Methods For Improving Wound Healing With And Cosmetic Use Of The Formulations |
| IL207113A | Erythropietin And Fibronectin Compositions For Bone Regeneration |
| IL203964A | Erythropoietin And Fibronectin Compositions For Therapeutic And Cosmetic Applications |
| US20190192637A1 | Erythropoietin And Fibronectin Compositions For Therapeutic And Cosmetic Applications |
| US20190117740A1 | Erythropoietin And Fibronectin Compositions For Therapeutic And Cosmetic Applications |
| US20170056480A1 | Erythropoietin And Fibronectin Compositions For Therapeutic And Cosmetic Applications |
| US20140154205A1 | Erythropoietin And Fibronectin Compositions For Therapeutic And Cosmetic Applications |
| US20110123481A1 | Erythropoietin And Fibronectin Compositions For Therapeutic And Cosmetic Applications |
| CN102906250A | Methods And Compositions For Enhancing Fat Graft Survival |
| WO2017037655A1 | Topical Erythropoietin Formulations And Methods For Improving Wound Healing With And Cosmetic Use Of The Formulations |
| WO2009022338A3 | Erythropoietin And Fibronectin Compositions For Therapeutic And Cosmetic Applications |
| AT1236923T | Erythropoietin- Und Fibronectin-Zusammensetzungen Zur Knochenneubildung |
| AT989684T | Erythropoetin- Und Fibronektin-Zusammensetzungen Für Therapeutische Anwendungen |
| BR112018004361A2 | Topical Erythropoietin Formulations And Methods To Improve Wound Healing And Cosmetic Use Of Formulations |
What are Remedor Biomed key innovation segments?
What Technologies are Covered by Remedor Biomed?
The chart below distributes patents filed by Remedor Biomed